“…Since brain BDNF crosses the blood-brain barrier (Pan, Banks, Fasold, Bluth, & Kastin, 1998), is seems reasonable to assume that blood BDNF protein levels resemble those in the brain. This assumption is reinforced by several evidences: serum BDNF is positively associated to cortical levels of Nacetyl aspartate, a marker of neuronal integrity (Lang, Hellweg, Seifert, Schubert, & Gallinat, 2007); brain pathologies are associated to a decrease in BDNF levels in brain and blood, whereas successful therapeutic interventions can increase BDNF levels in these two compartments (Autry & Monteggia, 2012;Diniz & Teixeira, 2011;Gezen-Ak et al, 2013); the severity of neurological symptoms, such as the degree of cognitive impairment, is correlated to serum BDNF levels (Corrêa et al, 2016;K€ uster et al, 2017;Zhang et al, 2012). Based on these evidences, we assume that central and peripheral levels of BDNF are associated.…”